PB Fintech Target Cut to Rs 1,100 as Nomura Slashes FY28 Profit

What happened

Nomura has cut its target price on PB Fintech, the parent of Policybazaar and Paisabazaar, to Rs 1,100 from Rs 1,590. It kept its Neutral rating.1114 The cut came with much lower earnings estimates. Nomura reduced its FY28 net profit forecast by 72% and its FY29 forecast by 51%.1315 Some headlines suggested that PB Fintech cut the target itself. In fact the move came from Nomura's October 8 research note, titled "What if...?", and the company did not revise anything.15

The new target is only about 5.8% above the stock's October 7 close of Rs 1,040.1114 The market did not take the note as a new shock. Shares fell to Rs 996 on October 8.1 By Friday morning they were trading about 2.5% higher at Rs 1,020.50.15 That reaction makes sense. Nomura's note mostly confirms a view that the market had already priced in during two weeks of heavy selling.

The regulatory trigger

The cause is a consultation paper published on September 23, 2026 by the Insurance Regulatory and Development Authority of India (IRDAI). It proposes strict caps on insurance commissions and distribution expenses.12 The draft would tighten insurers' Expenses of Management, set commission limits by segment, and ban "dark patterns" on insurance websites. Under the proposal, customers would see product and pricing information without first having to hand over personal details.3 One report says the proposals could cut commissions by between one-half and two-thirds in health, term and motor insurance.14 Payouts would also be lower for products sold through open-architecture channels such as brokers and banks.6

The market reacted hard. PB Fintech fell 36% on September 24, a record single-day drop that removed more than Rs 31,000 crore of market value.67 The selling continued for seven straight sessions, a total decline of about 48%. Market capitalisation fell from about Rs 87,290 crore to Rs 45,174 crore.814 On October 1 the stock dropped below its 2021 IPO price of Rs 980, which erased roughly five years of gains for public shareholders.147 Reuters reported that the company lost more than $3 billion in value in the first wave of selling alone.20

Inside Nomura's model

Nomura's central assumption is that PB Fintech leaves its point-of-sales person (POSP) business completely. The Policybazaar marketplace, the Dubai operation and the corporate segment keep their earlier forecasts.1115 Nomura also lowered its take-rate assumptions to match the proposed caps. As a result, its insurance premium estimates fall 13% for FY28 and 19% for FY29.15 It expects EBITDA margin to drop to 7.9% in FY28 and recover to 18.2% in FY29.1116

It may look odd that a 72% profit cut still leaves the target above the share price. The explanation is on the cost side. Nomura cut its estimates of total expenses by 40% for FY28 and 48% for FY29, because a company that exits a segment also stops spending on it.13 In its discounted cash flow model, Nomura lowered long-run revenue growth for FY26–50 to 13.2% a year from 15.1%.1516 One outlet described that figure as cash-flow growth over FY26–30, but most coverage agrees it is a revenue assumption running to FY50.14 The Rs 1,100 target implies price-to-earnings multiples of 70 times for September 2028 and 40 times for September 2029.11

The note also includes two scenarios that would raise the fair value. If IRDAI raises the health insurance commission caps by two percentage points, FY28 and FY29 profit estimates rise 37% and 19% above the base case, and fair value moves to Rs 1,335.15 Nomura links this case to PB Fintech's argument that its help for customers at hospital discharge is a real service.15 In the second scenario, Policybazaar starts selling traditional savings insurance, which would make up 0.5% to 1.1% of premiums. That would give a fair price of Rs 1,366.11

Brokerages now broadly agree

The most notable point across the coverage is how closely brokerage targets now match. Bernstein cut its target by 53% to Rs 1,085 from Rs 2,310 on September 30. HSBC cut to Rs 1,150 on September 25, and Motilal Oswal also has Rs 1,150.132 Within a fortnight, most targets moved into a narrow range around the current share price. Before the paper, views had been spread far apart.13

The brokers still differ on the details. Bernstein assumed the POSP business would shrink and later removed its revenue from the model entirely, calling it low-margin and possibly unviable.20 Nomura goes a step further by assuming a full exit, and that explains much of its deeper profit cut.13 Jefferies is the main exception. It kept a Buy rating at Rs 1,540, left its earnings estimates unchanged, and instead lowered its valuation multiple by 30% to 18 times FY30 EBITDA.2 Morgan Stanley estimated that the value of the health business could fall 60–70%, while the life insurance business stays broadly steady.3

The ratings also tell different stories. Bernstein kept an Outperform rating even with a lower target than Nomura. It called the next 18 months "do-or-die" and said it was modelling a "max pain" case with no regulatory rollback.202 Nomura's Neutral rating at almost the same price level points to a key difference. Bernstein appears to value what the company might look like after the transition, while Nomura is more doubtful about getting there. Both firms model a smaller, leaner business. They disagree on whether the stock already reflects that.

Why this matters for fintech

The fintech angle matters more than the stock price. PB Fintech's main business is digital customer acquisition. It runs a marketplace that gathers demand, captures leads and earns commissions from insurers.9 The IRDAI proposals affect both parts of that model. Commission caps reduce what each policy earns. The dark-patterns rule targets the data-capture step that lets platforms collect contact details before showing prices.3 Bernstein said it has not yet included the dark-patterns risk in its forecasts. That means the profit cuts may still understate the full effect.20

This is a wider lesson for insurtech and embedded-finance models in India. Turtlemint fell 20% on the day of the announcement, and insurers, banks and NBFCs that depend on bancassurance income also sold off.8 Growth in digital distribution depended on regulated product economics, and the regulator now wants a bigger share of that value to reach policyholders. Some coverage says the reforms aim to lower insurance costs and widen coverage.3

The company's possible responses are also limited. Morgan Stanley noted that PB Fintech is looking at manufacturing, reinsurance broking and new products. It is also seeking regulation for managing general agents (MGAs), firms that underwrite and sell policies on insurers' behalf.3 However, shares fell 8% after the IRDAI chairman explained why the company is unlikely to get an MGA licence.4 Jefferies expects lower hiring and marketing spend in the near term, plus efforts to reduce losses at Paisabazaar and the UAE business.23

Analysis: what to watch

The most important point is that the rules are still a draft. PB Fintech has told the exchanges that the paper is open for public consultation, is not a final order, and that it is giving feedback to IRDAI.12 Comments are due by October 25, 2026.18 Nomura's scenarios show what is at stake. A two-point change in health commission caps alone moves fair value by more than 20%.15

Not every investor has given up on the stock. HDFC Mutual Fund bought about Rs 321 crore of shares at Rs 1,282.30 on the day of the crash.7 Aggregated data still shows 11 of 22 covering analysts rating it a buy or strong buy.9 The company will also report its September-quarter results soon. Its trading window has been closed since October 1.10

The consensus reading is that PB Fintech is now valued as a business shrinking under regulation, not as a fast-growing platform. That seems right while the caps remain as drafted. Nomura's 72% cut is not a forecast of failure. It describes a business that has to restructure. The pressure on the stock is likely to continue until IRDAI finalises the rules and the company shows how much cost it can actually remove.